Skip to content
drillr.ai
Sign up

ACRV

Acrivon Therapeutics, Inc. Common Stock

NASDAQ · Healthcare · Biotechnology · US

$2.13
+3.40%
Ask drillr
0
Insider buys (3m)
9
Insider sells (3m)
-$39.8K
Net value (3m)
+46.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 2, 2026Levin Michaela · officer: Chief Business OfficerA-Award130,000$2.09
Sep 2, 2026Levin Michaela · officer: Chief Business OfficerA-Award30,000$0.00
Aug 27, 2026Blume-Jensen Peter · director, officer: President and CEOSale14,036$2.21
Aug 20, 2026Miller Mary · officer: Chief Legal OfficerSale185$2.01
Aug 20, 2026Gamelin Erick · officer: Chief Development OfficerSale400$2.01
Aug 20, 2026Devroe Eric · officer: Chief Operating OfficerSale604$2.01
Aug 20, 2026Blume-Jensen Peter · director, officer: President and CEOSale1,229$2.01
Aug 20, 2026Blume-Jensen Peter · director, officer: President and CEOSale484$2.01
Aug 20, 2026Peterson Katharine · officer: Chief Accounting OfficerSale101$2.01
Aug 6, 2026Levy Adam D. · officer: Chief Financial OfficerSale1,142$1.57
Jul 23, 2026Miller Mary · officer: Chief Legal OfficerSale573$1.76
Jun 22, 2026Palani Santhosh · directorA-Award20,275$1.52
Jun 22, 2026Magovcevic-Liebisch Ivana · directorA-Award20,275$1.52
Jun 22, 2026DiRocco Derek · directorA-Award20,275$1.52
Jun 22, 2026BAUM CHARLES M · directorA-Award20,275$1.52
Jun 22, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: A-Award20,275$1.52
Jun 22, 2026TOMSICEK MICHAEL JOHN · directorA-Award20,275$1.52
Jun 22, 2026Shacham Sharon · directorA-Award20,275$1.52
May 26, 2026Blume-Jensen Peter · director, officer: President and CEOF-InKind13,729$1.79
May 20, 2026Blume-Jensen Peter · director, officer: President and CEOA-Award180,095$0.00
May 20, 2026Blume-Jensen Peter · director, officer: President and CEOA-Award72,706$0.00
May 20, 2026Devroe Eric · officer: Chief Operating OfficerA-Award72,981$0.00
May 20, 2026Gamelin Erick · officer: Chief Development OfficerA-Award38,584$0.00
May 20, 2026Levy Adam D. · officer: Chief Financial OfficerA-Award46,167$0.00
May 20, 2026Miller Mary · officer: Chief Legal OfficerA-Award49,830$0.00
May 20, 2026Mirza Mansoor Raza · officer: Chief Medical OfficerA-Award38,817$0.00
May 20, 2026Peterson Katharine · officer: Chief Accounting OfficerA-Award14,227$0.00
May 20, 2026BAUM CHARLES M · directorA-Award9,366$0.00
May 20, 2026DiRocco Derek · directorA-Award9,366$0.00
May 20, 2026Magovcevic-Liebisch Ivana · directorA-Award9,366$0.00
Institutional positioning

13F filings over the trailing two quarters

New 11Increased 12Reduced 11Sold out 44
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Unchanged8,340,508May 15, 2026
SANDS CAPITAL VENTURES, LLCUnchanged2,122,605May 8, 2026
WELLINGTON MANAGEMENT GROUP LLPUnchanged888,130May 15, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased845,973May 13, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased758,440May 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position722,035May 15, 2026
MARSHALL WACE, LLPIncreased560,436May 15, 2026
TWO SIGMA INVESTMENTS, LPReduced389,395May 15, 2026
JANE STREET GROUP, LLCReduced239,691May 12, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased236,391May 15, 2026
BLACKROCK, INC.Increased208,939May 13, 2026
GSA CAPITAL PARTNERS LLPNew Position186,716May 8, 2026
BRIDGEWAY CAPITAL MANAGEMENT, LLCIncreased158,900May 15, 2026
GOLDMAN SACHS GROUP INCIncreased119,422Mar 25, 2026
VANGUARD FIDUCIARY TRUST CONew Position107,529May 8, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026